Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc（CNTA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cnta · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$42.00
Consensus
$39.50
-0.4% upside
Low
$38.00
Median: $39 · Last Close: $39.65
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$39.50
-0.4% upside
High Target
$42
5.9%
Low Target
$38
-4.2%
Current Price
$39.65
as of today
Based on analyst price targets, the CNTA stock price prediction for the next 12 months ranges from $38 to $42. The consensus CNTA price forecast of $39.50 implies -0.4% upside from the current price of $39.65.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $39.69 | ↑ 0.09% |
1-day model range: $39.68–$39.7. Peak: $39.7 (+0.09%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $67 | +68.1% |
| 2028 | $94 | +136.7% |
| 2029 | $117 | +194.8% |
| 2030 | $134 | +238.1% |
| 2031 | — | +268.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CNTA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-20 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2026-04-02 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2026-04-01 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2026-03-31 | Needham | Downgrade ↓ | Buy→Hold |
| 2026-03-31 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2026-01-29 | Truist Securities | Maintains | Buy→Buy |
| 2026-01-08 | Truist Securities | Maintains | Buy→Buy |
| 2026-01-02 | Chardan Capital | Maintains | Buy→Buy |
| 2025-12-10 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-12-01 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Centessa Pharmaceuticals plc (CNTA) stock. Of the recent 42 rating actions, 3 were upgrades and 6 were downgrades. 14 analysts currently cover CNTA.
分析师推荐趋势
CNTA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$3M
↓ 98.3% YoY
Revenue Next Year
$25M
↑ 709.7% YoY
EPS This Year
$-1.69
EPS Next Year
$-1.81
↑ 7.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast CNTA EPS of $-1.69 for the current fiscal year, based on estimates from 2 analysts. The CNTA revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CNTA 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CNTA 的共识目标价为 $39.50（-0.4% 上行空间），分析师共识为 Buy。
CNTA 的短期预测（明日）为 $39.69（+0.09%）。 CNTA 对 2027 年的股价预测均值为 $67。 CNTA 对 2030 年的预测区间为 $134–$135。
Centessa Pharmaceuticals plc 在 NASDAQ 上市，代码 CNTA。CNTA 在 2027 年的整体展望偏积极，在覆盖分析师中约 57% 对应 Buy 共识。
常见问题
CNTA 预测 · 8 个问题根据 14 位华尔街分析师，CNTA 的 12 个月平均目标价为 $39.50，最高 $42.00、最低 $38.00。若有图表，中位目标价可在上方查看。相对当前价 $39.65，隐含约 -0.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.